Successful treatment of pyoderma gangrenosum using adalimumab in a patient undergoing hemodialysis

J Dermatol. 2022 Dec;49(12):e435-e436. doi: 10.1111/1346-8138.16526. Epub 2022 Jul 21.

Authors

Mariko Seishima¹, Makiko Sasaki¹, Shigeyuki Sugie²

Affiliations

¹ Department of Dermatology, Asahi University Hospital, Gifu, Japan.
² Department of Pathology, Asahi University Hospital, Gifu, Japan.

PMID: 35862244
DOI: 10.1111/1346-8138.16526

No abstract available

Publication types

Letter

MeSH terms

Adalimumab / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use
Colitis, Ulcerative*
Humans
Pyoderma Gangrenosum* / drug therapy
Renal Dialysis

Substances

Adalimumab
Antibodies, Monoclonal, Humanized